Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

The prognosis of advanced esophageal cancer patients is poor. Trimodality therapy of surgical resection plus neoadjuvant chemoradiotherapy (CRT) has been developed to improve survival through locoregional control, leading to prevention of micrometastasis. We investigated whether or not neoadjuvant C...

Descripción completa

Detalles Bibliográficos
Autores principales: FUJIWARA, YOSHINORI, YOSHIKAWA, REIGETSU, KAMIKONYA, NORIHIKO, NAKAYAMA, TSUYOSHI, KITANI, KOTARO, TSUJIE, MASANORI, YUKAWA, MASAO, INOUE, MASATOSHI, YAMAMURA, TAKEHIRA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583592/
https://www.ncbi.nlm.nih.gov/pubmed/22664791
http://dx.doi.org/10.3892/or.2012.1847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583592/
https://www.ncbi.nlm.nih.gov/pubmed/22664791
http://dx.doi.org/10.3892/or.2012.1847

Ejemplares similares